Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021

Qin-Ying She1, Li-Juan Li1, Ming-Hong Liu1

  • 1Department of Nephrology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.

Frontiers in Pharmacology
|October 14, 2022
PubMed

Insights

Fibroblast growth factor 21 (FGF-21) research shows peripheral metabolic effects and drug development are key topics. Emerging trends include central FGF-21 effects and non-metabolic disease impacts.

Area of Science:

  • Metabolic Regulation
  • Endocrinology
  • Pharmacology

Background:

  • Fibroblast growth factor 21 (FGF-21) is a key metabolic regulator with significant pharmacological potential.
  • Despite extensive research, clinical trial outcomes for FGF-21 have been inconsistent, prompting further investigation into its therapeutic value.

Purpose of the Study:

  • To conduct a bibliometric analysis of FGF-21 research over the past 20 years.
  • To identify key research topics, influential contributors, and emerging trends in the field.
  • To evaluate the current state and future directions of FGF-21 research.

Main Methods:

  • Collected 2,490 publications on FGF-21 from the Web of Science Core Collection (Science Citation Index Expanded).
  • Utilized HistCite, VOSviewer, and CiteSpace for bibliometric analysis and visualization.
  • Analyzed publication trends, leading countries, institutions, authors, journals, and keywords.

Main Results:

  • Research on FGF-21 has involved 12,872 authors from 2,628 institutions across 77 countries.
  • The United States led in FGF-21 research, with Alexei Kharitonenkov, Steven A. Kliewer, and David J. Mangelsdorf as highly influential scholars.
  • Key research areas included physiological roles, clinical translation, and FGF-21 drug development, with endocrinology journals being central.

Conclusions:

  • Peripheral metabolic effects, drug development, and translational research on metabolic diseases are the primary focuses in FGF-21 studies.
  • Future research is expected to concentrate on central FGF-21 effects and its impact on non-metabolic diseases, representing emerging trends.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
2.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K